My PAH Patient.

Slides:



Advertisements
Similar presentations
Upfront Combination Therapy vs Step-Up Approach for PAH:
Advertisements

Exploring Early Combination Therapy in PAH
NOACs for Cancer-Associated Thrombosis:
Chronic Hepatitis C Virus Infection
Program Themes. Consulting on Common Concerns in PAH: How Would You Manage These Patients?
Renal Denervation Two Late-Breaking Clinical Trials.
Managing Bleeds in Patients Anticoagulated With Warfarin and Other Agents.
Risk Stratification in PAH: What Do the Latest Data Suggest?
A Paradigm Shift in PAH.
Preventing SCD With a WCD: Reviewing the Results of the VEST Trial
Setting the Stage – PAH Therapy Trials Current PAH Pharmacotherapies.
PAD Patients vs Post-ACS Patients:
The Latest Data on Oral Prostacyclin Therapy in PAH
CV Risk Management in T2DM: What Did We Learn From EASD 2016?
Statin Selection in Special Patient Populations: A Case Challenge
Cost Effectiveness and Optimal Outcomes in HF
All About PAH:.
Antithrombotics and PAD: A New Paradigm in Practice
Addressing Iron Deficiency in Chronic HF
Chronic Idiopathic Urticaria
PAH Therapy Revisited.
PAH in Adults CHEST Guideline and Expert Panel Report: Grading of Evidence
Improving Risk Assessment and Early Diagnosis in PAH
WHO Clinical Classification of PH Complex Cases in PH.
Selected Highlights of the Latest Advances in PAH
CoreValve US Pivotal Trial High-Risk Arm Device and Access Routes.
Program Goals. Treatment-Naive Patients With PAH What Do We Know and What Choices Do We Have?
How to Optimize TAVR Outcomes
Evolving Science of PAH Treatment
Risk Assessment in PAH.
2013 World Symposium on PH CTEPH Diagnosisa 2013 World Symposium on PH (cont) CTEPH Treatmenta.
Risk Stratification in CAD and PAD
Examining the Latest Evidence in PAH
CV Risk Management in T2DM: What Did We Learn from ADA 2016?
Translating the Latest and Greatest Advances in PAH Into Clinical Practice.
Treatment of Thromboembolic Disease The Need for Multiple Perspectives
Using Heart Rate as a Biomarker in Clinical Practice.
EARLY Combination Therapy in PAH: What Every Cardiologist Needs to Know.
Hyperkalemia in the Hospital
Case Study 56-year-old Presents With 1 Year of Worsening Dyspnea
Case #1 Case #1 (cont) Case #1 (cont)
Navigating Treatment Options in PAH
Preventing Clinical Events in PAH
Trials and Tribulations in VTE: How Do Real-World Data Fit In?
PAH and Prostacyclin Pathways in Focus
When Is Intrathecal Drug Delivery Appropriate?
PAH-Related Morbidity as a Predictor of Mortality
CV Risk Reduction with Diabetes Drugs -- Should Cardiologists or Diabetologists Take the Lead?
New Strategies to Reduce HF Readmissions
PEARLS OF WISDOM WITH COMBINATION THERAPY IN PAH
Oral Prostacyclin Pathway Agents in PAH
Group 1 PAH: Current Therapies
Iron Deficiency in Heart Failure
The Rising Crisis of Prediabetes Diagnosis and Management of the Patient With Prediabetes.
Program Goals Background: Anticoagulation in Patients With VTE.
Elevated Admission Plasma Glucose Following ACS
Perspective on the Multidisciplinary Management of PAH
Live on PAH: Breathing Life Into Patients With PAH
When Is Intrathecal Drug Delivery Appropriate?
HF-Related Hospitalization and Readmissions
Incorporating New PAH Treatments Into Clinical Practice
PAH Pathways: What Do the Data Tell Us?”
Clinical Comparisons in CTEPH
Championing Evidence-Based Care in Patients With Acute Low Back Pain
Pulmonary Arterial Hypertension and Hospitalizations
What's New in PAH?.
Top Tips in Evidence-Based Care for HFrEF
Key Data on Improving Outcomes in HF Patients
The Power of As-Treated Analyses
What's New in NOACs in AF?.
Presentation transcript:

My PAH Patient

End Points in PAH Clinical Trials

REVEAL Registry™ Hospitalization Worsens Long-Term Outcomes

Criteria for PAH-Related Hospitalization

REVEAL PAH-Related Hospitalization Worsens Long-Term Outcome

Impact of Hospitalization

Paradigm Shift in PAH Treatment

SERAPHIN – Contd. PAH Population

Treatment Goals

PAH Clinical Trials Evaluating Morbidity and Mortality End Points

SERAPHIN Primary End Point

SERAPHIN (cont)

SERAPHIN Effect on Hospitalizations

SERAPHIN – Contd.

Conclusions

Abbreviations

References

References (cont)

References (cont)